CIDRAP newsletters options
COVID caused 62% of deaths, but it ranged from 77% to 82% among minority officers.
Electronic algorithms developed by an antibiotic stewardship team at the University of Pennsylvania were highly accurate in detecting inappropriate antibiotic prescribing for bronchitis and pharyngitis, scientists reported yesterday in Open Forum Infectious Diseases.
People who believe in conspiracies about the COVID-19 pandemic are at an increased risk of experiencing anxiety and depression, according to new research presented at the European Congress of Psychiatry and published in Frontiers in Psychiatry.
Cases in nonendemic countries continue to climb, with more than 780 reported in the past 3 weeks.
Voting behavior seemed to be a proxy for compliance with and support for public health measures.
Meanwhile, FDA advisers will meet tomorrow to discuss emergency use of the Novavax COVID vaccine.
A study of samples from two Brazilian rivers found a high incidence of colistin-resistant bacteria and MCR-1 producers, Brazilian and Portuguese researchers reported today in the Journal of Global Antimicrobial Resistance.
Nearly all long-COVID patients at an Ohio health system reported moderate to severe fatigue, and about half said they had serious sleep disruptions, which were up to three times more common in Black participants, according to findings presented this week at the Associated Professional Sleep Societies' annual meeting.
The research abstract was published May 25 in an online supplement of Sleep.
Screenings for breast cancer and cervical cancer fell 6% and 11%, respectively.
Also, an expert weighs in on crafting clear public health messaging that doesn't stigmatize yet doesn't miss key groups.
Over the study period, the proportion who were boosted rose from 49% to 85%.
Experts say the vaccine will likely provide meaningful protection against Omicron.
A study of 4,737 COVID-19 patients in Israel conducted during the Omicron surge concludes that Pfizer's antiviral drug Paxlovid roughly halves the risk of severe COVID-19 or death, according to findings published yesterday in Clinical Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Pfizer and BioNTech submitted an EUA request for their vaccine in kids 6 months to 4 years old.
Moms' vaccination provided infants 71% protection against Delta and 33% against Omicron.
Also, a study notes potential undetected spread of the disease in Europe at least since early April.
An analysis of studies published over the past two decades shows that human intestinal carriage of multidrug-resistant (MDR) Escherichia coli has risen substantially in healthcare and community settings around the world, researchers reported today in JAC-Antimicrobial Resistance.
Compared with reverse-transcription polymerase chain reaction (RT-PCR) testing, dogs can detect COVID-19 infections via scent with high sensitivity (97%)—though lower specificity (91%)—even when patients are asymptomatic, according to a study in PLOS One yesterday.
Too-high pulse oximetry readings led clinicians to believe patients weren't ill enough for certain therapies.
